304 related articles for article (PubMed ID: 26923247)
1. Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study.
Prasad V; Sainz-Esteban A; Arsenic R; Plöckinger U; Denecke T; Pape UF; Pascher A; Kühnen P; Pavel M; Blankenstein O
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1593-600. PubMed ID: 26923247
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDOPA PET/CT imaging of insulinoma revisited.
Imperiale A; Sebag F; Vix M; Castinetti F; Kessler L; Moreau F; Bachellier P; Guillet B; Namer IJ; Mundler O; Taïeb D
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):409-18. PubMed ID: 25367749
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma.
Sharma P; Arora S; Karunanithi S; Khadgawat R; Durgapal P; Sharma R; Kandasamy D; Bal C; Kumar R
Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):69-76. PubMed ID: 24740163
[TBL] [Abstract][Full Text] [Related]
4. Early
Leroy-Freschini B; Amodru V; Addeo P; Sebag F; Vix M; Brunaud L; Klein M; Bahougne T; Bachellier P; Castinetti F; Goichot B; Chevalier E; Taieb D; Imperiale A
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):686-695. PubMed ID: 30617961
[TBL] [Abstract][Full Text] [Related]
5. Value of
Imperiale A; Boursier C; Sahakian N; Ouvrard E; Chevalier E; Sebag F; Addeo P; Taïeb D
J Nucl Med; 2022 Mar; 63(3):384-388. PubMed ID: 34272321
[TBL] [Abstract][Full Text] [Related]
6. Utility of
Kalff V; Iravani A; Akhurst T; Pattison DA; Eu P; Hofman MS; Hicks RJ
Intern Med J; 2021 Oct; 51(10):1657-1664. PubMed ID: 33314504
[TBL] [Abstract][Full Text] [Related]
7.
Shah R; Sehemby M; Garg R; Purandare N; Hira P; Mahajan A; Lele V; Malhotra G; Verma P; Rojekar A; Dalvi A; Uchino S; Rastogi S; Lila A; Patil V; Shah N; Bandgar T
Clin Endocrinol (Oxf); 2022 Feb; 96(2):190-199. PubMed ID: 34498757
[TBL] [Abstract][Full Text] [Related]
8. Role of 68Ga-DOTATOC PET/CT in Insulinoma According to 3 Different Contexts: A Retrospective Study.
Moreau PL; Aveline C; Christin-Maitre S; Chanson P; Dubreuil O; Rusu T; Montravers F
Clin Nucl Med; 2022 May; 47(5):394-401. PubMed ID: 35307723
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas.
Wild D; Christ E; Caplin ME; Kurzawinski TR; Forrer F; Brändle M; Seufert J; Weber WA; Bomanji J; Perren A; Ell PJ; Reubi JC
J Nucl Med; 2011 Jul; 52(7):1073-8. PubMed ID: 21680696
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.
Luo Y; Pan Q; Yao S; Yu M; Wu W; Xue H; Kiesewetter DO; Zhu Z; Li F; Zhao Y; Chen X
J Nucl Med; 2016 May; 57(5):715-20. PubMed ID: 26795291
[TBL] [Abstract][Full Text] [Related]
12.
Tuzcu SA; Pekkolay Z; Kılınç F; Tuzcu AK
J Nucl Med Technol; 2017 Sep; 45(3):198-200. PubMed ID: 28798227
[TBL] [Abstract][Full Text] [Related]
13. Value of the
Fastrez M; Artigas C; Sirtaine N; Wimana Z; Caillet M; Rozenberg S; Flamen P
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():69-74. PubMed ID: 28342392
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4-based imaging in endogenous hyperinsulinemic hypoglycaemia cohort: A tertiary Endocrine centre experience.
Garg R; Shah R; Tiwari A; Purandare N; Lele VR; Malhotra G; Verma P; Gosavi V; Dalvi A; Kumar Jaiswal S; Patil V; Ramteke-Jadhav S; Lila A; Shah N; Bandgar T
Clin Endocrinol (Oxf); 2020 Dec; 93(6):678-686. PubMed ID: 32716527
[TBL] [Abstract][Full Text] [Related]
15. Ectopic insulinoma: a systematic review.
Guerrero-Pérez F; Vilarrasa N; Huánuco LV; Busquets J; Secanella L; Vercher-Conejero JL; Vidal N; Näf Cortés S; Villabona C
Rev Endocr Metab Disord; 2023 Dec; 24(6):1135-1146. PubMed ID: 37434098
[TBL] [Abstract][Full Text] [Related]
16. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
Recent Results Cancer Res; 2013; 194():353-71. PubMed ID: 22918768
[TBL] [Abstract][Full Text] [Related]
17. 68Ga DOTA-Exendin PET/CT for Detection of Insulinoma in a Patient With Persistent Hyperinsulinemic Hypoglycemia.
Parihar AS; Vadi SK; Kumar R; Mittal BR; Singh H; Bal A; Walia R; Shukla J; Sinha SK
Clin Nucl Med; 2018 Aug; 43(8):e285-e286. PubMed ID: 29877881
[TBL] [Abstract][Full Text] [Related]
18.
El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
[TBL] [Abstract][Full Text] [Related]
19. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
Madrzak D; Mikołajczak R; Kamiński G
Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
[TBL] [Abstract][Full Text] [Related]
20. Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan.
Nockel P; Babic B; Millo C; Herscovitch P; Patel D; Nilubol N; Sadowski SM; Cochran C; Gorden P; Kebebew E
J Clin Endocrinol Metab; 2017 Jan; 102(1):195-199. PubMed ID: 27805844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
